B

Bio-Rad Laboratories IncClass A
D

BIO

342.98
USD
-1.67
(-0.48%)
مغلق
حجم التداول
4,268
الربح لكل سهم
11
العائد الربحي
-
P/E
-12
حجم السوق
9,602,330,460
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    B
    BMRN
    0.260
    (0.42%)
    61.570 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    I
    ICUI
    -2.490
    (-1.50%)
    163.600 USD
    ILMN
    ILMN
    -0.725
    (-0.53%)
    136.625 USD
    I
    INCY
    -0.500
    (-0.69%)
    71.950 USD
    M
    MASI
    2.130
    (1.25%)
    172.100 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Bio/Rad Laboratories IncClass A

القطاع: Healthcare
الصناعة: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.